Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

Area of Science:

• Immunology
• Neuroimmunology
• Autoimmune Diseases

Background:

• Multiple sclerosis (MS) pathogenesis is linked to myelin-reactive CD4+ T cells, including Th1 and Th17 subsets.
• The precise T cell lineages and polarizing cytokines (IL-12, IL-23) driving MS and its animal models remain debated.
• Understanding T cell plasticity and diversity is crucial for developing effective MS therapies.

Purpose of the Study:

• To investigate the roles of IL-12 and IL-23 in T cell differentiation and their capacity to induce central nervous system (CNS) axon damage.
• To determine if T helper cell plasticity is essential for experimental autoimmune encephalomyelitis (EAE) development.
• To correlate T cell responses in MS patients with disease severity.

Main Methods:

• Induction and assessment of experimental autoimmune encephalomyelitis (EAE) using stable murine Th1 and Th17 cells.
• Evaluation of T cell plasticity and cytokine production (IFN-γ, IL-17) in response to myelin basic protein in MS patients.
• Brain MRI analysis to quantify T1 lesion burden in MS patients.

Main Results:

• Both stable Th1 and Th17 cells independently induced EAE without exogenous IL-23 or IL-12, respectively.
• Plastic Th17 cells demonstrated potent demyelination and axon damage capabilities.
• MS patients with mixed IFN-γ and IL-17 responses showed higher T1 lesion burden, indicating greater permanent axon damage.

Conclusions:

• The development of autoimmune demyelinating disease, like EAE, is not universally dependent on IL-23 and Th17 plasticity.
• Distinct T helper cell polarizing factors and effector subsets can drive autoimmune CNS damage.
• These findings support a personalized medicine approach for managing multiple sclerosis based on individual patient immune profiles.